These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 28452996)
1. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157. Rojas-Rivera D; Delvaeye T; Roelandt R; Nerinckx W; Augustyns K; Vandenabeele P; Bertrand MJM Cell Death Differ; 2017 Jun; 24(6):1100-1110. PubMed ID: 28452996 [TBL] [Abstract][Full Text] [Related]
2. RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions. Estornes Y; Aguileta MA; Dubuisson C; De Keyser J; Goossens V; Kersse K; Samali A; Vandenabeele P; Bertrand MJ Cell Death Dis; 2014 Dec; 5(12):e1555. PubMed ID: 25476903 [TBL] [Abstract][Full Text] [Related]
3. Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications. Krishnamoorthy J; Rajesh K; Mirzajani F; Kesoglidou P; Papadakis AI; Koromilas AE Cell Cycle; 2014; 13(5):801-6. PubMed ID: 24401334 [TBL] [Abstract][Full Text] [Related]
5. Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and Survival. Moore PC; Qi JY; Thamsen M; Ghosh R; Peng J; Gliedt MJ; Meza-Acevedo R; Warren RE; Hiniker A; Kim GE; Maly DJ; Backes BJ; Papa FR; Oakes SA Cancer Res; 2019 Dec; 79(24):6190-6203. PubMed ID: 31672843 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Atkins C; Liu Q; Minthorn E; Zhang SY; Figueroa DJ; Moss K; Stanley TB; Sanders B; Goetz A; Gaul N; Choudhry AE; Alsaid H; Jucker BM; Axten JM; Kumar R Cancer Res; 2013 Mar; 73(6):1993-2002. PubMed ID: 23333938 [TBL] [Abstract][Full Text] [Related]
7. The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors. Mahameed M; Wilhelm T; Darawshi O; Obiedat A; Tommy WS; Chintha C; Schubert T; Samali A; Chevet E; Eriksson LA; Huber M; Tirosh B Cell Death Dis; 2019 Apr; 10(4):300. PubMed ID: 30931942 [TBL] [Abstract][Full Text] [Related]
8. Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways. Rozpedek W; Nowak A; Pytel D; Diehl JA; Majsterek I Curr Mol Med; 2017; 17(2):118-132. PubMed ID: 28266275 [TBL] [Abstract][Full Text] [Related]
9. New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1α signaling is essential for promoting adaptation and survival to hypoxia. Cojocari D; Vellanki RN; Sit B; Uehling D; Koritzinsky M; Wouters BG Radiother Oncol; 2013 Sep; 108(3):541-7. PubMed ID: 23830192 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment. Rozpędek W; Pytel D; Dziki Ł; Nowak A; Dziki A; Diehl JA; Majsterek I Pol Przegl Chir; 2017 Jun; 89(3):7-10. PubMed ID: 28703114 [TBL] [Abstract][Full Text] [Related]
11. GSK2656157, a PERK inhibitor, reduced LPS-induced IL-1β production through inhibiting Caspase 1 activation in macrophage-like J774.1 cells. Ando T; Komatsu T; Naiki Y; Takahashi K; Yokochi T; Watanabe D; Koide N Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):298-302. PubMed ID: 27251848 [TBL] [Abstract][Full Text] [Related]
12. Neurite atrophy and apoptosis mediated by PERK signaling after accumulation of GM2-ganglioside. Virgolini MJ; Feliziani C; Cambiasso MJ; Lopez PH; Bollo M Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):225-239. PubMed ID: 30389374 [TBL] [Abstract][Full Text] [Related]
13. Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis. Bugallo R; Marlin E; Baltanás A; Toledo E; Ferrero R; Vinueza-Gavilanes R; Larrea L; Arrasate M; Aragón T Cell Death Dis; 2020 May; 11(5):397. PubMed ID: 32457286 [TBL] [Abstract][Full Text] [Related]
14. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease. Mercado G; Castillo V; Soto P; López N; Axten JM; Sardi SP; Hoozemans JJM; Hetz C Neurobiol Dis; 2018 Apr; 112():136-148. PubMed ID: 29355603 [TBL] [Abstract][Full Text] [Related]
15. Activation of ER stress and apoptosis by hydrogen peroxide in HeLa cells: protective role of mild heat preconditioning at 40°C. Pallepati P; Averill-Bates DA Biochim Biophys Acta; 2011 Dec; 1813(12):1987-99. PubMed ID: 21875624 [TBL] [Abstract][Full Text] [Related]
16. [Niskocząsteczkowe inhibitory szlaku adaptacyjnej odpowiedzi na stres zależnego od kinazy PERK jako nowatorska strategia terapeutyczna w leczeniu choroby Alzheimera]. Rozpędek W; Pytel D; Diehl JA; Majsterek I Pol Merkur Lekarski; 2019 Jan; 46(271):9-15. PubMed ID: 30810108 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy. Vandewynckel YP; Laukens D; Bogaerts E; Paridaens A; Van den Bussche A; Verhelst X; Van Steenkiste C; Descamps B; Vanhove C; Libbrecht L; De Rycke R; Lambrecht BN; Geerts A; Janssens S; Van Vlierberghe H Hepatol Int; 2015 Jan; 9(1):93-104. PubMed ID: 25598862 [TBL] [Abstract][Full Text] [Related]
18. Necroptosis activates UPR sensors without disrupting their binding with GRP78. Liang W; Qi W; Geng Y; Wang L; Zhao J; Zhu K; Wu G; Zhang Z; Pan H; Qian L; Yuan J Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544877 [TBL] [Abstract][Full Text] [Related]
19. A Systems Biological View of Life-and-Death Decision with Respect to Endoplasmic Reticulum Stress-The Role of PERK Pathway. Márton M; Kurucz A; Lizák B; Margittai É; Bánhegyi G; Kapuy O Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067773 [TBL] [Abstract][Full Text] [Related]
20. From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors. Scarpellini C; Valembois S; Goossens K; Vadi M; Lanthier C; Klejborowska G; Van Der Veken P; De Winter H; Bertrand MJM; Augustyns K Front Chem; 2023; 11():1160164. PubMed ID: 37090247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]